SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-005846
Filing Date
2024-08-16
Accepted
2024-08-16 17:00:24
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sunshine_i10q-063024.htm   iXBRL 10-Q 773112
2 GRAPHIC sunshine_logo.jpg GRAPHIC 6215
3 CERTIFICATION sunshine_ex3101.htm EX-31.1 13657
4 CERTIFICATION sunshine_ex3102.htm EX-31.2 13642
5 CERTIFICATION sunshine_ex3201.htm EX-32.1 5945
  Complete submission text file 0001683168-24-005846.txt   4011587

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sbfm-20240630.xsd EX-101.SCH 33099
7 XBRL CALCULATION FILE sbfm-20240630_cal.xml EX-101.CAL 45073
8 XBRL DEFINITION FILE sbfm-20240630_def.xml EX-101.DEF 157461
9 XBRL LABEL FILE sbfm-20240630_lab.xml EX-101.LAB 284181
10 XBRL PRESENTATION FILE sbfm-20240630_pre.xml EX-101.PRE 255974
62 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10q-063024_htm.xml XML 416052
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41282 | Film No.: 241217406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)